針劑接續輸注案：藥品仿單警語之違反【學習式判解評析】 試閱
Successive Infusion of Parenteral Drugs: The Violation of Warning on Drug Label
年輕成年女性因急性腎盂炎，經醫囑第三代頭孢子菌類抗生素與葡萄糖酸鈣接續輸注後，發生癲癇與休克，主張醫師違反當時藥品仿單於48小時內禁藥物接續施用之警語而有過失，且護理師輸注方法亦有過失致藥品混合而生沉澱，起訴請求損害賠償，本件經更三審始告確定。本文擇違反仿單警語之法評價、科學證據之運用及過失與因果關係論證層次三項進行評析。
The plaintiff was admitted due to acute pyelonephritis, complicated by epilepsy and shock after successively infusion of third generation of pansporin and calcium gluconate, and claimed for damages for malpractice due to the physician’s ignorance of the warnings of drug label and nurse’s violation against the standard of infusion procedures. This article comments on jurisdictions’ reasoning with special emphasis on the label warning, scientific evidence and the different elements in the argument of liability.
064-089
